The VM contributes to tumor proliferation and invasion in many types of cancers through the upregulation of several proteins, including matrix metalloproteinase (MMP)-2, MMP-9, vascular endothelial growth factor (VEGF), and growth factor-β1 (TGF-β1) (5–9). This evidence concerns the gene MMP9 and cancer.